Further Information
FRS2, fibroblast growth factor receptor substrate 2, FRS2A, FRS2alpha, SNT, SNT-1, SNT1, FGFR signalling adaptor, FGFR substrate 2, FGFR-signaling adaptor SNT, suc1-associated neurotrophic factor target 1
Peptide ELISA: antibody detection limit dilution 1:128000.Western Blot:Approx 60kDa band observed in lysates of undifferentiated cell line 3T3-L1 (calculated MW of 57.0kDa according to NP_006645.3). Recommended concentration: 0.1-0.3ug/ml. Primary incubation was 1 hour. Preliminary testing was unsuccessful on Human and Pig for this particular batch.
- Wang X, Asmann YW, Erickson-Johnson MR, Oliveira JL, Zhang H, Moura RD, Lazar AJ, Lev D, Bill K, Lloyd RV, Yaszemski MJ, Maran A, Oliveira AM.High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Human, Dog, Pig, Cow
The immunogen for this antibody is: C-SRDEDDNLGPKTPS
10818
fibroblast growth factor receptor substrate 2
FRS2
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 60kDa
NP_006645.3
110347408
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Neuroscience, Signal Transduction
Reported variants represent identical protein: NP_001265284.1, NP_001265286.1, NP_001265283.1, NP_001265285.1, NP_001265282.1, NP_006645.3, NP_001036020.1, NP_001265280.1
Q8WU20